Article
Accelerated drug resistant variant discovery with an enhanced, scalable mutagenic base editor platform
2023-10-26
Abstract excerpt
<h4>ABSTRACT</h4> Personalized cancer therapeutics bring directed treatment options to patients based on the genetic signatures of their tumors. Unfortunately, tumor genomes are remarkably adaptable, and acquired resistance to these drugs through genetic means is an all-too-frequent occurrence. Identifying mutations that promote resistance within drug-treated patient populations can be cost, resource, and time in...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 5f34c903-ba11-587b-9168-62582f8307f4
- DOI
- 10.1101/2023.10.25.564011
